Ironwood Pharmaceuticals IRWD EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's EBITDA margin?
- Ironwood Pharmaceuticals (IRWD) reported EBITDA margin of 55.9% in Q1 2026.
- How has Ironwood Pharmaceuticals's EBITDA margin changed year-over-year?
- Ironwood Pharmaceuticals's EBITDA margin increased by 226.5% year-over-year, from 17.1% to 55.9%.
- What is the long-term trend for Ironwood Pharmaceuticals's EBITDA margin?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's EBITDA margin has grown at a -2.1% compound annual growth rate (CAGR), from 37.6% to 33.9%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.